Spots Global Cancer Trial Database for primary brain tumors
Every month we try and update this database with for primary brain tumors cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Basket Study of Entrectinib (RXDX-101) for the Treatment of Patients With Solid Tumors Harboring NTRK 1/2/3 (Trk A/B/C), ROS1, or ALK Gene Rearrangements (Fusions) | NCT02568267 | Breast Cancer Cholangiocarcin... Colorectal Canc... Head and Neck N... Lymphoma, Large... Melanoma Neuroendocrine ... Non-Small Cell ... Ovarian Cancer Pancreatic Canc... Papillary Thyro... Primary Brain T... Renal Cell Carc... Sarcomas Salivary Gland ... Adult Solid Tum... | Entrectinib | 18 Years - | Hoffmann-La Roche | |
| Study of 4-Demethyl-4-cholesteryloxycarbonylpenclome (DM-CHOC-PEN) in Patients With Brain Tumors | NCT02038218 | Primary Brain T... Metastatic Mali... | 4-Demethyl-4-ch... | 18 Years - | DEKK-TEC, Inc. | |
| Combination of Sorafenib and Radiation for Brain Metastases and Primary Brain Tumors | NCT00639262 | Brain Metastase... Primary Brain T... | Sorafenib Temozolomide Radiotherapy | 18 Years - | Thomas Jefferson University | |
| Fluorescence-guided Resection of Malignant Gliomas With 5-Aminolevulinic Acid | NCT00241670 | Brain Cancer Brain Tumors Cancer of Brain Primary Brain T... Brain Tumor, Pr... | 5-aminolevulini... | 18 Years - 72 Years | medac GmbH | |
| A Home-Based Approach Study to Evaluate the Efficacy and Safety of Alectinib in Locally-Advanced or Metastatic ALK-Positive Solid Tumors | NCT04644315 | Neoplasms Colorectal Neop... Melanoma Pancreatic Neop... Sarcoma Ovarian Neoplas... Brain Neoplasms Thyroid Neoplas... Neuroendocrine ... Cholangiocarcin... Salivary Gland ... Head and Neck N... Thyroid Cancer,... Lymphoma, Large... Neoplasms by Si... Respiratory Tra... Thoracic Neopla... Respiratory Tra... Carcinoma, Bron... Bronchial Neopl... Intestinal Neop... Gastrointestina... Digestive Syste... Digestive Syste... Gastrointestina... Colonic Disease... Intestinal Dise... Central Nervous... | Alectinib | 18 Years - | Hoffmann-La Roche | |
| Study of Oral JYP0322 in Patients With Locally Advanced or Metastatic Cancer Targeting ROS1 Molecular Fusion. | NCT06128148 | Protein Kinase ... Other Protocol ... Lung Neoplasms Brain Neoplasms | JYP0322 | 18 Years - | Guangzhou JOYO Pharma Co., Ltd | |
| Tumor Hypoxia With HX4 PET in Several Diseases | NCT02584400 | Prostatic Neopl... Esophageal Neop... Neoplasm Metast... Rectal Neoplasm... Brain Neoplasm,... | Injection with ... | 18 Years - | Maastricht Radiation Oncology | |
| Safety and Imaging Study of GC1008 in Glioma | NCT01472731 | Primary Brain T... | 89Zr-GC1008 GC1008 | 18 Years - 75 Years | University Medical Center Groningen | |
| Study of 4-Demethyl-4-cholesteryloxycarbonylpenclome (DM-CHOC-PEN) in Patients With Brain Tumors | NCT02038218 | Primary Brain T... Metastatic Mali... | 4-Demethyl-4-ch... | 18 Years - | DEKK-TEC, Inc. | |
| A Home-Based Approach Study to Evaluate the Efficacy and Safety of Alectinib in Locally-Advanced or Metastatic ALK-Positive Solid Tumors | NCT04644315 | Neoplasms Colorectal Neop... Melanoma Pancreatic Neop... Sarcoma Ovarian Neoplas... Brain Neoplasms Thyroid Neoplas... Neuroendocrine ... Cholangiocarcin... Salivary Gland ... Head and Neck N... Thyroid Cancer,... Lymphoma, Large... Neoplasms by Si... Respiratory Tra... Thoracic Neopla... Respiratory Tra... Carcinoma, Bron... Bronchial Neopl... Intestinal Neop... Gastrointestina... Digestive Syste... Digestive Syste... Gastrointestina... Colonic Disease... Intestinal Dise... Central Nervous... | Alectinib | 18 Years - | Hoffmann-La Roche | |
| Metformin in Children With Relapsed or Refractory Solid Tumors | NCT01528046 | Solid Tumors Primary Brain T... | Vincristine Irinotecan Temozolomide Metformin | 1 Year - 18 Years | H. Lee Moffitt Cancer Center and Research Institute | |
| Fluorescence-guided Resection of Malignant Gliomas With 5-Aminolevulinic Acid | NCT00241670 | Brain Cancer Brain Tumors Cancer of Brain Primary Brain T... Brain Tumor, Pr... | 5-aminolevulini... | 18 Years - 72 Years | medac GmbH | |
| Assistance in Neurosurgery (ExtempoRMN) | NCT02272452 | Primary Brain T... Glioma | High-Resolution... | 18 Years - | University Hospital, Strasbourg, France | |
| Combination of Sorafenib and Radiation for Brain Metastases and Primary Brain Tumors | NCT00639262 | Brain Metastase... Primary Brain T... | Sorafenib Temozolomide Radiotherapy | 18 Years - | Thomas Jefferson University |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
